Organogenesis Holdings Profit Margin vs. Gross Profit
| ORGO Stock | USD 3.60 0.08 2.17% |
Organogenesis Holdings Net Profit Margin |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.7542 |
|
|
For Organogenesis Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Organogenesis Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Organogenesis Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Organogenesis Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Organogenesis Holdings over time as well as its relative position and ranking within its peers.
Organogenesis |
Organogenesis Holdings' Revenue Breakdown by Earning Segment
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.05) | Revenue Per Share 3.446 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0164 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Organogenesis Holdings Gross Profit vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Organogenesis Holdings's current stock value. Our valuation model uses many indicators to compare Organogenesis Holdings value to that of its competitors to determine the firm's financial worth. Organogenesis Holdings is rated below average in profit margin category among its peers. It is rated below average in gross profit category among its peers . At this time, Organogenesis Holdings' Net Profit Margin is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organogenesis Holdings' earnings, one of the primary drivers of an investment's value.Organogenesis Gross Profit vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Organogenesis Holdings |
| = | (0.02) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Organogenesis Holdings |
| = | 345.87 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Organogenesis Gross Profit Comparison
Organogenesis Holdings is currently under evaluation in gross profit category among its peers.
Organogenesis Holdings Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Organogenesis Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Organogenesis Holdings will eventually generate negative long term returns. The profitability progress is the general direction of Organogenesis Holdings' change in net profit over the period of time. It can combine multiple indicators of Organogenesis Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 12.5 M | 13.2 M | |
| Net Income From Continuing Ops | 13 M | 13.6 M | |
| Income Before Tax | 10.4 M | 10.9 M | |
| Total Other Income Expense Net | -2.1 M | -2.2 M | |
| Net Income Applicable To Common Shares | 17.9 M | 18.8 M | |
| Net Income | 4.9 M | 5.2 M | |
| Income Tax Expense | 5.4 M | 5.7 M | |
| Net Interest Income | -1.7 M | -1.7 M | |
| Interest Income | 10.3 M | 10.9 M | |
| Non Operating Income Net Other | -11.7 K | -11.1 K | |
| Change To Netincome | 13.7 M | 14.4 M | |
| Net Income Per Share | 0.04 | 0.04 | |
| Income Quality | 6.25 | 6.56 | |
| Net Income Per E B T | 0.48 | 0.45 |
Organogenesis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Organogenesis Holdings. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Organogenesis Holdings position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Organogenesis Holdings' important profitability drivers and their relationship over time.
Use Organogenesis Holdings in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organogenesis Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will appreciate offsetting losses from the drop in the long position's value.Organogenesis Holdings Pair Trading
Organogenesis Holdings Pair Trading Analysis
The ability to find closely correlated positions to Organogenesis Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organogenesis Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organogenesis Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organogenesis Holdings to buy it.
The correlation of Organogenesis Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organogenesis Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organogenesis Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organogenesis Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Organogenesis Holdings position
In addition to having Organogenesis Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
To fully project Organogenesis Holdings' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Organogenesis Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Organogenesis Holdings' income statement, its balance sheet, and the statement of cash flows.